- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, December 6, 2019
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article appearing in Purdue University’s Research Foundation News, titled “An engineering approach to reduce the pain of chemotherapy,” referenced a May 2019 In Focus Blog article published on the website of The American Journal of Managed Care® (AJMC®), titled “Chemotherapy Demand Will Rise Significantly by 2040, and Workforce Will Need to Expand With It.”
Valdosta Daily Times’ article, “Nearly a Quarter of a Million Prescribers Using Surescripts Prescription Price Transparency Tool to View Patient Medication Cost Information,” cited a study published in the January 2006 issue of AJMC®, titled “Varying Pharmacy Benefits With Clinical Status: The Case of Cholesterol-lowering Therapy.” The study stressed the importance of cholesterol-lowering therapy in reducing hospitalizations and emergency department use.
AJMC®’s sister site, The Center for Biosimilars®, was featured in the December 2, 2019, daily regulatory news and intelligence briefing from Regulatory Focus. The article, “Mylan and Biocon Launch Biosimilar Trastuzumab, Ogivri, in the United States,” was included in the section In Focus: US.
A piece by McKnight’s Long-Term Care News referenced a study published in the January 2019 issue of AJMC®: “Mind the Gap: The Potential of Alternative Health Information Exchange.” The study found that open forms of health information exchange selection tools remain critical for comprehensive coverage of patient transitions.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
